Introduction of a second MenB vaccine into Europe – needs and opportunities for public health-Reference-Cited by-同舟云学术

Introduction of a second MenB vaccine into Europe – needs and opportunities for public health

Published:2019-03-01 Issue:3 Volume:18 Page:225-239
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Findlow Jamie¹,Nuttens Charles²,Kriz Paula³

Affiliation:

1. Medical & Scientific Affairs – International Developed Markets, Pfizer Limited, Tadworth, UK

2. Medical & Scientific Affairs – International Developed Markets, Pfizer, Paris, France

3. Centre for Epidemiology and Microbiology – National Institute of Public Health, Prague, Czech Republic

Funder

Pfizer Inc

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2019.1578217

Reference107 articles.

1. World Health Organization. Meningococcal meningitis fact sheet no 141. [cited 2018 Jun 19]. Available from: http://www.who.int/mediacentre/factsheets/fs141/en/#

2. Pathophysiology, Treatment and Outcome of Meningococcemia: A Review and Recent Experience

3. Complications and sequelae of meningococcalinfections in children

4. Global epidemiology of invasive meningococcal disease

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MAGLIO study: epideMiological Analysis on invasive meninGococcaL disease in Italy: fOcus on hospitalization from 2015 to 2019;Internal and Emergency Medicine;2023-08-01

2. An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease;Science Translational Medicine;2023-06-21

3. Understanding barriers to vaccination against invasive meningococcal disease: a survey of the knowledge gap and potential solutions;Expert Review of Vaccines;2023-05-17

4. The propositive study: Immunogenicity and safety of a four‐component recombinant protein‐based vaccine against MenB and a quadrivalent conjugate MenACWY vaccine in people living with HIV;HIV Medicine;2023-04-23

5. Genomic characterization of Japanese meningococcal strains isolated over a 17-year period between 2003 and 2020 in Japan;Vaccine;2023-01